Niagen Bioscience (NAGE) is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended September 2025. This widely-known ...

The Chhattisgarh government has declared the recently released Chhattisgarhi film ‘Balidani Raja Guru Balakdas’, based on the life of Satnami sect leader Raja Guru Balakdas, tax-free in the state. The ...

We got a small bullish gap up, some follow-through, and what looks like a bullish engulfing candle two sessions ago - basically buyers absorbing the last wave of selling. Right now the stock’s stuck ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...

Niagen Bioscience (NAGE) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to break-even earnings per share a year ago. These ...

Niagen Bioscience's stock price is breaking out with strong fundamentals, proprietary IP, and a leadership position in the NAD+ longevity market. Revenue and margins are rising, driven by Tru Niagen e ...

In a remarkable display of market momentum, NAGE stock has reached a new 52-week high, with shares trading at $13.58. The company, now valued at over $1 billion, has earned a "GREAT" financial health ...

Fintel reports that on May 27, 2025, Canaccord Genuity initiated coverage of Niagen Bioscience (NasdaqCM:NAGE) with a Buy recommendation. As of May 7, 2025, the average one-year price target for ...

A large exercise of company stock options by Robert Fried, Chief Executive Officer at Niagen Bioscience NAGE was disclosed in a new SEC filing on April 9, as part of an insider exercise. What Happened ...

As part of this transition, the Company will deploy a follow-up announcement with additional updates regarding the name change, rebrand, and future initiatives. No action is required by existing ...